Cytokines in sleep regulation

https://doi.org/10.1016/0960-5428(95)00007-OGet rights and content

Abstract

The central thesis of this essay is that the cytokine network in brain is a key element in the humoral regulation of sleep responses to infection and in the physiological regulation of sleep. We hypothesize that many cytokines, their cellular receptors, soluble receptors, and endogenous antagonists are involved in physiological sleep regulation. The expressions of some cytokines are greatly amplified by microbial challenge. This excess cytokine production during infection induces sleep responses. The excessive sleep and wakefulness that occur at different times during the course of the infectious process result from dynamic changes in various cytokines that occur during the host's response to infectious challenge. Removal of any one somnogenic cytokine inhibits normal sleep, alters the cytokine network by changing the cytokine mix, but does not completely disrupt sleep due to the redundant nature of the cytokine network. The cytokine network operates in a paracrine/autocrine fashion and is responsive to neuronal use. Finally, cytokines elicit their somnogenic actions via endocrine and neurotransmitter systems as well as having direct effects on neurons and glia. Evidence in support of these postulates is reviewed in this essay.

References (181)

  • E.G. Gutierrez et al.

    Murine tumor necrosis factor alpha is transported from blood to brain in the mouse

    J. Neuroimmunol.

    (1993)
  • G.A. Higgins et al.

    Induction of interleukin-1β mRNA in adult rat brain

    Molec. Brain Res.

    (1991)
  • J.S. Hunt et al.

    Tumor necrosis factor-alpha gene expression in the tissues of normal mice

    Cytokine

    (1992)
  • T. Janet et al.

    Ultrastructural localization of fibroblast growth factor in neuron of rat brain

    Neurosci. Lett.

    (1987)
  • L. Kapás et al.

    Humoral regulation of sleep

    Int. Rev. Neurobiol.

    (1993)
  • L. Kapás et al.

    Inhibition of nitric oxide synthesis inhibits rat sleep

    Brain Res.

    (1994)
  • K. Kinouchi et al.

    Identification and characterization of receptors for tumor necrosis factor-alpha in the brain

    Biochem. Biophys. Res. Commun.

    (1991)
  • J.M. Krueger

    Somnogenic activity of immune response modifiers

    TIPS

    (1990)
  • J.M. Krueger et al.

    Sleep as a host defense: its regulation by microbial products and cytokines

    Clin. Immunol. Immunopathol.

    (1990)
  • J.M. Krueger et al.

    The composition of sleep-promoting factor isolated from human urine

    J. Biol. Chem.

    (1982)
  • J.M. Krueger et al.

    Peptidoglycans as promoters of slow-wave sleep. II. Somnogenic and pyrogenic activities of some naturally occurring muramyl peptides; correlations with mass spectrometric structure determination

    J. Biol. Chem.

    (1984)
  • J.M. Krueger et al.

    Bacterial peptidoglycan as modulators in sleep. II. Effects of muramyl peptides on the structure of rabbit sleep

    Brain Res.

    (1987)
  • J.M. Krueger et al.

    Interferon alpha-2 enhances slow-wave sleep in rabbits

    Int. J. Immunopharmac.

    (1987)
  • R.M. Lechan et al.

    Immunoreactive interleukin-1β localization in the rat forebrain

    Brain Res.

    (1990)
  • J.A. Abraham et al.

    Nucleotide sequence of bovine clone encoding the angiogenic protein, basic fibroblast growth factor

    Science

    (1986)
  • M.C. Aguila

    Growth hormone-releasing factor increases somatostatin release and mRNA levels in the rat periventricular nucleus via nitric oxide by activation of guanylate cyclase

  • F. Arenzana-Seidedos et al.

    Phosphatidylcholine hydrolysis activates NF-κB and increases human immunodeficiency virus replication in human monocytes and T lymphocytes

    J. Virol.

    (1993)
  • N.A. Ayers et al.

    Brain nitric oxide synthase activity and sleep

    Sleep Res.

    (1995)
  • W.A. Banks et al.

    Human interleukin (IL) 1α, murine IL-1α and murine IL-1β are transported from blood to brain in the mouse by a shared saturable mechanism

    J. Pharmac. Expl Ther.

    (1991)
  • E.N. Benveniste

    Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action

    Cell Physiol.

    (1992)
  • M. Braun et al.

    Prostaglandin D2 relaxes bovine coronary arteries by endothelium-dependent nitric oxide-mediated cGMP formation

    Circ. Res.

    (1992)
  • C.D. Breder et al.

    Interleukin-1 immunoreactive innervation of the human hypothalamus

    Science

    (1988)
  • C.D. Breder et al.

    Distribution and characterization of tumor necrosis factor-α-like immunoreactivity in the murine central nervous system

    J. Comp. Neurol.

    (1993)
  • C.D. Breder et al.

    Regional induction of tumor necrosis factor α expression in the mouse brain after systemic lipopolysaccharide administration

  • A.B. Cady et al.

    Somnogenic activities of synthetic lipid A

    Infect. Immun.

    (1989)
  • W.A. Carter et al.

    Viral infection and host defense

    Science

    (1974)
  • L. Chedid

    Immunopharmacology of muramyl peptides: new horizons

    Prog. Immunol.

    (1983)
  • I.Y. Chung et al.

    Tumor necrosis factor-alpha production by astrocytes: induction by lipopolysaccharide, interferon-gamma and interleukin-1

    J. Immunol.

    (1990)
  • E.T. Cunningham et al.

    Interleukin 1 receptors in the brain and endocrine tissues

    Immunol. Today

    (1993)
  • E.T. Cunningham et al.

    Localization of interleukin-1 receptor messenger RNA in murine hippocampus

    Endocrinology

    (1991)
  • N. Dafny

    Interferon modified EEG and EEG-like activity recorded from sensory, motor, and limbic system structures in freely behaving rats

    Neurotoxicology

    (1983)
  • C. Damais et al.

    Production of lymphocyte activating factor in the absence of endogenous pyrogen by rabbit or human leukocytes stimulated by a muramyl dipeptide derivate

    Int. J. Immunol. Pharmac.

    (1982)
  • D.A. Davidson et al.

    Evidence for separate receptors for insulin-like growth factor-I in choroid plexus of rat brain by quantitative autoradiography

    J. Histochem. Cytochem.

    (1990)
  • T. Decker et al.

    Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages

    J. Immunol.

    (1987)
  • E. De Maeyer et al.

    Interferons and other Regulatory Cytokines

    (1988)
  • C.A. Dinarello

    Interleukin-1

    Rev. Infect. Dis.

    (1984)
  • C.A. Dinarello et al.

    Induction of interleukin-1 by synthetic and naturally occurring muramyl peptides

  • J.M. Ding et al.

    Resetting the biological clock: mediation of nocturnal circadian shifts by glutamate and NO

    Science

    (1994)
  • C.A. Dionne et al.

    Cloning and expression of two distinct high-affinity receptors crossreacting with acidic and basic fibroblast growth factors

    EMBO J.

    (1990)
  • C.J. Dunn

    Cytokines as mediators of chronic inflammatory disease

  • Cited by (89)

    • Effects of an interleukin-1 receptor antagonist on human sleep, sleep-associated memory consolidation, and blood monocytes

      2015, Brain, Behavior, and Immunity
      Citation Excerpt :

      Sleep and the immune system are thought to interact such that sleep promotes immune defense and immune responses to infectious agents convey an enhancing influence on sleep (Besedovsky et al., 2012; Imeri and Opp, 2009). Stimulated by early work that identified a muramyl peptide, i.e., a fragment of bacterial cell walls, as potent sleep promoting factor (Krueger et al., 1982), the idea has been around for a long time that pro-inflammatory cytokines that are released in response to microbial challenge are involved in the homeostatic regulation of sleep, especially of slow wave sleep (SWS) (Krueger and Majde, 1994; Krueger et al., 1995). Interleukin-1 beta (IL-1) and tumor necrosis factor (TNF), two important cytokines mediating inflammatory processes, are considered major players in this context (Krueger et al., 2007).

    • Resolvins AT-D1 and E1 differentially impact functional outcome, post-traumatic sleep, and microglial activation following diffuse brain injury in the mouse

      2015, Brain, Behavior, and Immunity
      Citation Excerpt :

      It is unclear the cellular benefit or detriment of this acute post-traumatic sleep on recovery following TBI, however, we have previously shown immediate disruption of post-traumatic sleep does not worsen injury-induced motor or cognitive deficits (Rowe et al., 2014a) in the mouse. While the role of post-traumatic sleep in the pathophysiology of TBI remains unclear, data support a mechanistic link between inflammation and the induction of sleep (Krueger et al., 1995, 2007, 2001; Rowe et al., 2014). SPMs including RvE1 and AT-RvD1 may resolve inflammation resulting from TBI, as incorporated into the extended drug delivery design, and subsequently attenuate post-traumatic sleep disorders.

    • Sleep patterns in patients with acute coronary syndromes

      2010, Sleep Medicine
      Citation Excerpt :

      The acute phase of the illness and its consequences in circulating cytokines and other inflammatory mediators may play a major role in sleep disruption and deserve further research. The expression of many cytokines is upregulated in patients with ACS [35], with inflammatory cytokines having both somnogenic and sleep-inhibitory effects depending on the type, dose and circadian time of application, and it has been reported to influence sleep and sleep depth [36]. One possible limitation of our study is the absence of a control group.

    View all citing articles on Scopus
    View full text